Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dhi (DHX) Current Deferred Revenue (2016 - 2025)

Dhi has reported Current Deferred Revenue over the past 16 years, most recently at $39.7 million for Q4 2025.

  • Quarterly results put Current Deferred Revenue at $39.7 million for Q4 2025, down 11.75% from a year ago — trailing twelve months through Dec 2025 was $39.7 million (down 11.75% YoY), and the annual figure for FY2025 was $39.7 million, down 11.75%.
  • Current Deferred Revenue for Q4 2025 was $39.7 million at Dhi, down from $40.7 million in the prior quarter.
  • Over the last five years, Current Deferred Revenue for DHX hit a ceiling of $58.1 million in Q1 2023 and a floor of $39.7 million in Q4 2025.
  • Median Current Deferred Revenue over the past 5 years was $49.8 million (2022), compared with a mean of $48.8 million.
  • Biggest five-year swings in Current Deferred Revenue: increased 27.2% in 2021 and later dropped 11.75% in 2025.
  • Dhi's Current Deferred Revenue stood at $45.2 million in 2021, then increased by 10.85% to $50.1 million in 2022, then dropped by 1.31% to $49.5 million in 2023, then dropped by 9.16% to $44.9 million in 2024, then dropped by 11.75% to $39.7 million in 2025.
  • The last three reported values for Current Deferred Revenue were $39.7 million (Q4 2025), $40.7 million (Q3 2025), and $46.5 million (Q2 2025) per Business Quant data.